Gene therapy for deafness: How close are we?

Moser, T.

doi:10.1126/scitranslmed.aac7545

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Gene therapy for deafness: How close are we?

MPS-Authors

/persons/resource/persons15548

Moser, T.
Research Group of Synaptic Nanophysiology, MPI for Biophysical Chemistry, Max Planck Society;

External Resource

http://stm.sciencemag.org/content/7/295/295fs28.full-text.pdf+html
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Moser, T. (2015). Gene therapy for deafness: How close are we? Science Translational Medicine, 7(295): 295fs28. doi:10.1126/scitranslmed.aac7545.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0027-D641-5

Abstract

Virus-mediated transfer of genes encoding the mechanotransducer channel candidates TMC1 and TMC2 into hair cells of the ear partially restores hearing in animal models of human genetic deafness (Askew et al., this issue).